EDAP TMS reported EUR-7.37M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AngioDynamics USD -2.51M 5.41M Sep/2025
Boston Scientific USD 1.24B 190M Jun/2026
EDAP TMS EUR -7.37M 2.44M Mar/2026
Henry Schein USD 200M 6M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Veracyte USD 23.96M 4.88M Jun/2026